Title: Jain MR, et al. Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering effects in preclinical models. Pharmacol Res Perspect. 2015 Jun;3(3):e00136.
495399-09-2
1808255-64-2 | 2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine,trihydrochloride,hydrate | AA01EOQO
1374647-94-5 | 1,4-bis[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxobutyl]-1,4-diazoniabicyclo[2.2.2]octane,dibromide | AA01EP1L
296792-62-6 | 4-ethyl-2,6-bis(3-pyridinylmethylene)-cyclohexanone | AA01EPBD | MFCD01209975
1977535-33-3 | (3-nitrophenyl-1,2,3,4,5,6-13C6)hydrazine,monohydrochloride | AA01EPII
2441-64-7 | N-[(9Z,12Z)-1-oxo-9,12-octadecadien-1-yl]-L-phenylalanine | AA01EPNL
74723-10-7 | 5-(2-fluorophenyl)-1,3-dihydro-3-hydroxy-7-nitro-2H-1,4-benzodiazepin-2-one | AA01EPUJ | MFCD01762347
89771-78-8 | N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-hexadecanamide | AA01EQ3N
1310012-15-7 | N-[-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-(methyl-d3)-1-naphthalenemethanamine,monohydrochloride | AA01EQAX
107455-67-4 | 1-(4-Methylpyridin-2-yl)-1-phenylethan-1-ol | AA01EQMH | MFCD02929412
124337-38-8 | 1-[(2-Phenyl-1H-1,3-benzodiazol-1-yl)methyl]-1H-1,2,3-benzotriazole | AA01ER4S | MFCD00957698
